Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial
Elebsiran 和 PEG-IFNα 治疗慢性乙型肝炎感染：一项部分随机、开放标签的 II 期试验
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-04049-z
Wong, Grace Lai-Hung; Yuen, Man-Fung; Lin, Bingliang; Douglas, Mark W; Hu, Peng; Xie, Qing; Lv, Fangfang; Tak, Won Young; Leerapun, Apinya; Kim, Dong Joon; Tangkijvanich, Pisit; Lim, Young-Suk; Dai, Chia-Yen; O'Beirne, James; Weltman, Martin; Khemnark, Suparat; Piratvisuth, Teerha; Manasirisuk, Witsarut; Chen, Xinyue; Liu, Chun-Jen; Heo, Jeong; Lee, Jooho; Niu, Junqi; Kumar, Rahul; Kumar, Rajneesh; Zhu, Chong; Cao, Ke; Tian, Alex; Chen, Xiaofei; Zhu, Qing; Margolis, David; Jia, Jidong; Hong, Zhi
